Yahui Precision Medicine Fund

Yahui Precision Medicine Fund

Yahui Precision Medicine Fund was established as a dedicated investment vehicle for precision medicine, a field merging genomics, data science, and targeted therapy. The firm is headquartered in Beijing with an office in Shanghai, reflecting the dual hubs of China's life sciences ecosystem. The fund invests across precision medicine sub-sectors including genomics and sequencing, AI-based diagnostics, and targeted therapeutics. It covers early-stage through growth-stage companies, with a focus on technologies that enable personalized treatment. The firm participates in direct equity investments and may co-invest with other healthcare-focused funds. Geographically, its portfolio is concentrated in China, with selective exposure to global opportunities. The firm's team size and total assets under management are not publicly disclosed. No recent operational events or additional offices have been confirmed in public records. The fund operates independently, without a publicly identified parent entity or philanthropic arm. Yahui Precision Medicine Fund is a sector-specialist manager in a narrow but high-growth vertical. Its structural differentiator is its exclusive focus on precision medicine — a strategy that limits diversification but allows deep domain expertise in a field where scientific and regulatory complexity is high. The fund's China-based operations place it in a market with distinct regulatory pathways and patient data ecosystems.